Elucidating gsk-3 substrate and inhibitor binding sites as a tool for inhibitor refinement

被引：0
|
作者：
Licht-murava, A. [1 ]
Plotkin, B. [1 ]
Eisenstein, M. [2 ]
Eldar-Finkelman, H. [1 ]
机构：
[1] Tel Aviv Univ, IL-69978 Tel Aviv, Israel
[2] Weizmann Inst Sci, IL-76100 Rehovot, Israel
来源：
MOLECULAR BIOLOGY OF THE CELL | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
1485
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Disparate Effects of Lithium and a GSK-3 Inhibitor on Neuronal Oscillatory Activity in Prefrontal Cortex and Hippocampus
    Tuan Nguyen
    Fan, Theresa
    George, Susan R.
    Perreault, Melissa L.
    FRONTIERS IN AGING NEUROSCIENCE, 2018, 9
  • [42] GSK-3 inhibitor CHIR99021 enriches glioma stem-like cells
    Yang, Yang
    Wang, Qin-Qin
    Bozinov, Oliver
    Xu, Ru-Xiang
    Sun, Yi-Lin
    Wang, Shan-Shan
    ONCOLOGY REPORTS, 2020, 43 (05) : 1479 - 1490
  • [43] A novel GSK-3β inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
    Sereno, L.
    Coma, M.
    Rodriguez, M.
    Sanchez-Ferrer, P.
    Sanchez, M. B.
    Gich, I.
    Agullo, J. M.
    Perez, M.
    Avila, J.
    Guardia-Laguarta, C.
    Clarimon, J.
    Lleo, A.
    Gomez-Isla, T.
    NEUROBIOLOGY OF DISEASE, 2009, 35 (03) : 359 - 367
  • [44] In vitro binding of GSK-3 and PKC to ordered phosphorylation sites in HIV-2 Nef
    Brown, VN
    Samuel, KP
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 482A - 482A
  • [45] The mechanisms and effects of GSK-3β inhibitor on cellular multidrug resistance in colon carcer cells.
    Liu, Kunping
    Wu, Xuefang
    Luo, Feng
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [46] In silico interaction studies of first dual inhibitor against BACE-1/GSK-3β
    Kumar, Akhil
    Srivastava, Gaurava
    Sharma, Ashok
    2016 INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND SYSTEMS BIOLOGY (BSB), 2016,
  • [47] Discovery and Design of Novel Small Molecule GSK-3 Inhibitors Targeting the Substrate Binding Site
    Rippin, Ido
    Khazanov, Netaly
    Ben Joseph, Shirley
    Kudinov, Tania
    Berent, Eva
    Arciniegas Ruiz, Sara Melisa
    Marciano, Daniele
    Levy, Laura
    Gruzman, Arie
    Senderowitz, Hanoch
    Eldar-Finkelman, Hagit
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 17
  • [48] Novel benzothiazinones (BTOs) as allosteric modulator or substrate competitive inhibitor of glycogen synthase kinase 3β (GSK-3β) with cellular activity of promoting glucose uptake
    Zhang, Peng
    Li, Shufen
    Gao, Yang
    Lu, Wenbo
    Huang, Ke
    Ye, Deyong
    Li, Xi
    Chu, Yong
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (24) : 5639 - 5643
  • [49] Treatment with GSK-3 substrate-competitive inhibitor reduces neurotoxic brain Aβ levels and improves cognition in Alzheimer's disease animal model
    Avrahami, L.
    Farfara, D.
    Trudler, D.
    Frenkel, D.
    Eldar-Finkelman, H.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2012, 48 : S9 - S10
  • [50] Structure-based lead optimization of a novel glycogen synthase kinase 3 beta (GSK-3β) inhibitor
    Slater, Shuneize E.
    Fu, Gang
    Nael, Manal
    Avery, Mitchell A.
    Doerksen, Robert J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
12345